Subject(s)

Antineoplastic Agents/administration & dosage , Colonic Neoplasms/drug therapy , Neoplasm Recurrence, Local/prevention & control , Organoplatinum Compounds/administration & dosage , Clinical Trials as Topic , Colonic Neoplasms/pathology , Dose-Response Relationship, Drug , Germany , Humans , Neoplasm Recurrence, Local/drug therapy , Neoplasm Staging , Organoplatinum Compounds/adverse effects , Oxaliplatin , Treatment Outcome , United States